CHHiPvsPROFIT for Localized Prostate Cancer:A Retrospective Dosimetric Comparison of Organs at Risk.

被引：0
|
作者：
Ramia, P. [1 ]
Mkanna, A. [1 ]
Shahine, B. [1 ]
Makke, Z. [2 ]
Hilal, L. [1 ]
Geara, F. [1 ]
Adel, M. [1 ]
Olleik, F. [1 ]
Youssef, B. [1 ]
机构：
[1] Amer Univ Beirut, Radiat Oncol, Beirut, Lebanon
[2] Lebanese Univ, Phys, Beirut, Lebanon
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1202
引用
收藏
页码：S633 / S634
页数：3
相关论文
共 50 条
  • [21] Dosimetric considerations to determine the optimal technique for localized prostate cancer
    Kuess, P.
    Georg, D.
    Hopfgartner, J.
    Gora, J.
    Kragl, G.
    Berger, D.
    Goldner, G.
    Georg, P.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111
  • [22] Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer
    La Fauci, Francesco
    Augugliaro, Matteo
    Mazzola, Giovanni Carlo
    Comi, Stefania
    Pepa, Matteo
    Zaffaroni, Mattia
    Vincini, Maria Giulia
    Corrao, Giulia
    Mistretta, Francesco Alessandro
    Luzzago, Stefano
    Fodor, Cristiana
    Musi, Gennaro
    Gallo, Salvatore
    Petralia, Giuseppe
    De Cobelli, Ottavio
    Orecchia, Roberto
    Cattani, Federica
    Marvaso, Giulia
    Jereczek-Fossa, Barbara Alicja
    APPLIED SCIENCES-BASEL, 2022, 12 (21):
  • [23] Germline heterozygous BLM mutations and prostate cancer risk.
    Ledet, Elisa
    Antonarakis, Emmanuel S.
    Pritchard, Colin
    Isaacs, William B.
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [24] A dosimetric comparison for SBRT plans of localized prostate cancer between Cyberknife and Varian Truebeam STX device
    Senisik, Ahmet Murat
    Okutan, Murat
    Cakir, Aydin
    Celik, Ayca Iribas
    Saglam, Esra Kaytan
    Cevikbas, Gorkem
    Demir, Bayram
    APPLIED RADIATION AND ISOTOPES, 2023, 192
  • [25] The specific role of isoflavones in reducing prostate cancer risk.
    Kumar, NBK
    Allen, K
    Riccardi, D
    PowSang, J
    Seigne, J
    Helal, M
    Salup, R
    Besterman-Dahan, K
    Cantor, A
    JOURNAL OF NUTRITION, 2004, 134 (05): : 1257S - 1258S
  • [26] Role of inflammation and genes associations with Prostate cancer risk.
    Andavolu, Radhika Gade
    Rodriguez, Olivia
    Shaaf, Emon Gade
    FASEB JOURNAL, 2018, 32 (01):
  • [27] Lifetime occupational physical activity and prostate cancer risk.
    Parent, ME
    Siemiatycki, J
    Latreille, B
    Desy, M
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (11) : S30 - S30
  • [28] POSTOPERATIVE INTENSITY MODULATED RADIATION THERAPY IN HIGH RISK PROSTATE CANCER: A DOSIMETRIC COMPARISON
    Digesu, Cinzia
    Cilla, Savino
    De Gaetano, Andrea
    Massaccesi, Mariangela
    Macchia, Gabriella
    Ippolito, Edy
    Deodato, Francesco
    Panunzi, Simona
    Iapalucci, Chiara
    Mattiucci, Gian Carlo
    Angelo, Elisa D'
    Padula, Gilbert D. A.
    Valentini, Vincenzo
    Cellini, Numa
    Piermattei, Angelo
    Morganti, Alessio G.
    MEDICAL DOSIMETRY, 2011, 36 (03) : 231 - 239
  • [29] Dosimetric Comparison and Toxicity Analysis of Stereotactic Radiotherapy for High-Risk Prostate Cancer
    Callan, L.
    Bauman, G. S.
    Chen, J.
    Lock, M. I.
    Sexton, T. L.
    D'Souza, D. P.
    Rodrigues, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E268 - E269
  • [30] DOSIMETRIC COMPARISON AND TOXICITY ANALYSIS OF STEREOTACTIC RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER
    Callan, Laura
    Bauman, Glenn
    Chen, Jeff
    Lock, Michael
    Sexton, Tracy
    D'Souza, David
    Rodrigues, George
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S17 - S18
12345